Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Graph

CRL Revenue Flow

Filed revenue amounts for 2026-03-29 to 2026-06-27. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-27: Revenue $1.00B; Cost of revenue (m); Selling, general and administrative $228.90M; Income tax $53.93M.
  • 2026-03-28: Revenue $995.83M; Cost of revenue (m); Selling, general and administrative $159.42M; Income tax -$15.14M.
  • 2025-12-27: Revenue $994.23M*; Cost of revenue (m); Selling, general and administrative $196.14M*; Income tax -$17.81M*.
  • 2025-09-27: Revenue $1.00B; Cost of revenue (m); Selling, general and administrative $177.59M; Income tax $31.64M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CRL revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$195.79MService$808.29MRevenue$1.00BOperating income$119.89MOther income, net-$37.41MSelling, general& administrative$228.90MIncome tax$53.93M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CRL revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Asia Pacific$60.52MEurope$263.07MOther$13.12MCA$127.51MUS$539.86MRevenue$1.00BOperating income$119.89MOther income, net-$37.41MSelling, general& administrative$228.90MIncome tax$53.93M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CRL revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Discovery And SafetyAssessment Segment$606.51MManufacturingSupport Segment$188.10MResearch Models AndServices Segment$209.48MRevenue$1.00BOperating income$119.89MOther income, net-$37.41MSelling, general& administrative$228.90MIncome tax$53.93M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueSelling, general and administrativeIncome taxNet income
2026-06-27$1.00B(m)$228.90M$53.93M-$1.48M
2026-03-28$995.83M(m)$159.42M-$15.14M-$14.84M
2025-12-27$994.23M*(m)$196.14M*-$17.81M*-$276.56M*
2025-09-27$1.00B(m)$177.59M$31.64M$54.42M
2025-06-28$1.03B(m)$191.55M$18.73M$52.33M
2025-03-29$984.17M(m)$177.80M$10.10M$25.47M
2024-09-28$1.01B$660.74M$199.21M$20.95M$69.66M
2024-06-29$1.03B$672.40M$169.79M$25.39M$94.08M
2024-03-30$1.01B$666.72M$186.29M$24.53M$72.96M
2023-09-30$1.03B$664.78M$176.11M$24.85M$87.39M
2023-07-01$1.06B$660.96M$199.76M$29.22M$97.02M
2023-04-01$1.03B$651.72M$174.85M$27.09M$103.13M
2022-09-24$989.16M(m)$183.71M$25.50M$96.47M
2022-06-25$973.13M(m)$131.71M$33.45M$109.32M
2022-03-26$913.93M(m)$150.03M$15.62M$93.02M
2021-09-25$895.94M(m)$148.57M$18.11M$103.43M
2021-06-26$914.61M(m)$171.50M$37.58M$88.45M
2021-03-27$824.57M(m)$155.73M$2.37M$61.53M
2020-12-26$790.99M(m)(m)(m)$143.19M
2020-09-26$743.30M(m)$128.29M$32.66M$102.91M
2020-06-27$682.58M(m)$127.71M$16.28M$67.44M
2020-03-28$707.06M(m)$129.90M$4.62M$50.77M
2019-12-28$691.14M(m)(m)(m)$80.35M
2019-09-28$667.95M(m)$129.51M-$317.00K$72.81M
2019-06-29$657.57M(m)$135.94M$14.69M$43.73M
2019-03-30$604.57M(m)$122.57M$10.60M$55.13M
2018-12-29$601.53M(m)(m)(m)$59.66M
2018-09-29$585.29M(m)$113.03M$12.40M$60.37M
2018-06-30$585.30M(m)$120.53M$17.44M$53.71M
2018-03-31$493.97M(m)$103.37M$9.77M$52.63M
2017-12-30$478.48M(m)(m)(m)-$29.85M
2017-09-30$464.23M(m)$92.43M$19.95M$52.47M
2017-07-01$469.13M(m)$93.82M$22.24M$53.95M
2017-04-01$445.76M(m)$90.91M$31.08M$46.78M
2016-12-31$466.79M(m)(m)(m)(m)
2016-09-24$425.72M(m)$85.65M$15.56M$37.73M
2016-06-25$434.06M(m)$100.47M$18.84M$35.21M
2016-03-26$354.87M(m)$82.94M$13.97M$37.14M
2015-12-26$353.85M(m)(m)(m)(m)
2015-09-26$349.46M(m)$76.22M$15.26M$37.38M
2015-06-27$339.57M(m)$71.33M$11.08M$48.51M
2015-03-28$320.41M(m)$71.40M$331.00K$31.54M
2014-12-27$329.55M(m)(m)(m)(m)
2014-09-27$327.57M(m)$64.48M$11.58M(m)
2014-06-28$341.18M(m)$67.76M$14.08M(m)
2014-03-29$299.37M(m)$64.77M$10.36M(m)
2013-12-28$289.23M(m)(m)(m)(m)
2013-09-28$292.13M(m)$54.90M$11.39M(m)
2013-06-29$292.93M(m)$54.92M$8.22M(m)
2013-03-30$291.24M(m)$57.20M$9.72M(m)
2012-09-29$278.69M(m)$51.05M$6.01M(m)
2012-06-30$284.72M(m)$49.90M$9.45M(m)
2012-03-31$285.98M(m)$55.98M$8.68M(m)
2011-09-24$277.58M(m)$50.34M$5.63M(m)
2011-06-25$288.26M(m)$47.21M$8.65M$32.32M
2011-03-26$285.84M(m)$55.01M-$2.71M$31.34M
2010-12-25(m)(m)(m)(m)-$343.56M*
2010-09-25$270.88M(m)$48.01M$16.67M-$24.94M
2010-06-26$288.59M(m)$65.24M$7.17M$14.45M
2010-03-27$292.29M(m)$62.33M$6.74M$17.38M
2009-09-26$297.49M(m)$54.13M$6.90M$37.31M
2009-06-27$308.16M(m)$56.58M$13.63M$34.15M

Revenue and expense 6 month

Period endRevenueCost of revenueSelling, general and administrativeIncome taxNet income
2026-06-27$2.00B(m)$388.32M$38.79M-$16.32M
2025-06-28$2.02B(m)$369.35M$28.82M$77.80M
2024-06-29$2.04B$1.34B$356.08M$49.92M$167.04M
2023-07-01$2.09B$1.31B$374.60M$56.31M$200.15M
2022-06-25$1.89B(m)$281.74M$49.07M$202.34M
2021-06-26$1.74B(m)$327.23M$39.95M$149.98M
2020-06-27$1.39B(m)$257.61M$20.91M$118.20M
2019-06-29$1.26B(m)$258.51M$25.29M$98.86M
2018-06-30$1.08B(m)$223.90M$27.21M$106.34M
2017-07-01$914.89M(m)$184.73M$53.33M$100.73M
2016-06-25$788.92M(m)$183.42M$32.82M$72.35M
2015-06-27$659.99M(m)$142.73M$11.41M$80.05M
2014-06-28$640.55M(m)$132.52M$24.44M(m)
2013-06-29$584.17M(m)$112.12M$17.94M(m)
2012-06-30$570.70M(m)$105.88M$18.13M(m)
2011-06-25$574.11M(m)$102.22M$5.93M$63.65M
2010-06-26$580.88M(m)$127.57M$13.91M$31.84M
2009-06-27$609.68M(m)$118.76M$23.79M$59.56M

Revenue and expense 9 month

Period endRevenueCost of revenueSelling, general and administrativeIncome taxNet income
2025-09-27$3.02B(m)$546.94M$60.47M$132.22M
2024-09-28$3.05B$2.00B$555.29M$70.87M$236.70M
2023-09-30$3.12B$1.98B$550.71M$81.16M$287.54M
2022-09-24$2.88B(m)$465.46M$74.56M$298.82M
2021-09-25$2.64B(m)$475.81M$58.06M$253.40M
2020-09-26$2.13B(m)$385.90M$53.57M$221.11M
2019-09-28$1.93B(m)$388.02M$24.97M$171.67M
2018-09-29$1.66B(m)$336.94M$39.61M$166.71M
2017-09-30$1.38B(m)$277.16M$73.27M$153.20M
2016-09-24$1.21B(m)$269.07M$48.38M$110.08M
2015-09-26$1.01B(m)$218.95M$26.66M$117.43M
2014-09-27$968.11M(m)$197.00M$36.02M(m)
2013-09-28$876.30M(m)$167.02M$29.33M(m)
2012-09-29$849.39M(m)$156.92M$24.14M(m)
2011-09-24$851.68M(m)$152.56M$11.56M(m)
2010-09-25$851.76M(m)$176.56M$30.58M$6.89M
2009-09-26$907.17M(m)$172.89M$30.69M$96.87M

Revenue and expense 12 month

Period endRevenueSelling, general and administrativeIncome taxNet income
2025-12-27$4.02B$743.07M$42.66M-$144.34M
2024-12-28$4.05B$751.00M$67.82M$22.20M
2023-12-30$4.13B$747.86M$100.91M$474.62M
2022-12-31$3.98B$665.10M$130.38M$486.23M
2021-12-25$3.54B$619.92M$81.87M$390.98M
2020-12-26$2.92B$528.93M$81.81M$364.30M
2019-12-28$2.62B$517.62M$50.02M$252.02M
2018-12-29$2.27B$443.85M$54.46M$226.37M
2017-12-30$1.86B$371.27M$171.37M$123.36M
2016-12-31$1.68B$364.71M$66.83M$154.76M
2015-12-26$1.36B$300.41M$43.39M$149.31M
2014-12-27$1.30B$269.03M$47.67M$126.70M
2013-12-28$1.17B$225.69M$32.91M$102.83M
2012-12-29$1.13B$208.25M$27.63M(m)
2011-12-31$1.14B$198.65M$17.14M(m)
2010-12-25$1.13B$232.49M$23.00K-$336.67M
2009-12-26$1.17B$227.66M$40.35M$114.44M
2008-12-27$1.30B$223.94M$57.03M-$524.50M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71